Nektar Therapeutics (NKTR) Gross Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Nektar Therapeutics (NKTR) Gross Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | -65.00 |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 14,836.00 |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 589.00 |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 53.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 569.00 |
| 10 | Nektar Therapeutics | 2.45 Bn | 1.77 Bn | 3.04 Mn | -3,591.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,591.00 |
| Mar 31, 2026 | -3,822.00 |
| Dec 31, 2025 | -309.00 |
| Sep 30, 2025 | -6,629.00 |
| Jun 30, 2025 | -6,869.00 |
| Mar 31, 2025 | -14,360.00 |
| Dec 31, 2024 | -485.00 |
| Sep 30, 2024 | -2,434.00 |
| Jun 30, 2024 | -2,072.00 |
| Mar 31, 2024 | -2,744.00 |
| Dec 31, 2023 | -2,580.00 |
| Sep 30, 2023 | -3,294.00 |
| Jun 30, 2023 | -2,230.00 |
| Mar 31, 2023 | -2,516.00 |
| Dec 31, 2022 | -1,062.00 |
| Sep 30, 2022 | -418.00 |
| Jun 30, 2022 | -217.00 |
| Mar 31, 2022 | -214.00 |
| Dec 31, 2021 | -591.00 |
| Sep 30, 2021 | -408.00 |